Twelve metabolites of a synthetic cannabinoid, EAM-2201, have been tentatively identified in human hepatocytes in vitro, As well as in human liver and urine specimens in vivo for The 1st time. In vitro outcomes suggest that AM-2201 should be examined for probable pharmacokinetic drug interactions in vivo due to its https://billym382tiw4.wikisona.com/user